2019 年 1 月至 2020 年 9 月 COVID-19 大流行初期美国避孕服务商业保险索赔的变化。

IF 2.8 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Womens Health Issues Pub Date : 2024-03-01 DOI:10.1016/j.whi.2023.10.004
Kathryn M. Curtis PhD, Aniket D. Kulkarni MBBS, MPH, Antoinette T. Nguyen MD, MPH, Lauren B. Zapata PhD, Katherine Kortsmit PhD, MPH, Ruben A. Smith PhD, Maura K. Whiteman PhD
{"title":"2019 年 1 月至 2020 年 9 月 COVID-19 大流行初期美国避孕服务商业保险索赔的变化。","authors":"Kathryn M. Curtis PhD,&nbsp;Aniket D. Kulkarni MBBS, MPH,&nbsp;Antoinette T. Nguyen MD, MPH,&nbsp;Lauren B. Zapata PhD,&nbsp;Katherine Kortsmit PhD, MPH,&nbsp;Ruben A. Smith PhD,&nbsp;Maura K. Whiteman PhD","doi":"10.1016/j.whi.2023.10.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.</p></div><div><h3>Methods</h3><p><span><span><span>We analyzed commercial insurance claims using IQVIA PharMetrics Plus data from more than 9 million U.S. females aged 15–49 years, enrolled during any month, January 2019 through September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and </span>injectable contraception and monthly rates of pharmacy claims for </span>contraceptive pills, patches, and rings. We used Joinpoint </span>regression analysis<span> to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via telehealth.</span></p></div><div><h3>Results</h3><p>Monthly claims rates decreased for IUDs (−50%) and implants (−43%) comparing February 2020 with April 2020 but rebounded by June 2020. Monthly claims rates for injectables decreased (−19%) comparing January 2019 with September 2020, and monthly claims rates for pills, patches, and rings decreased (−22%) comparing July 2019 with September 2020. The percentage of claims for contraceptive counseling occurring via telehealth was low (&lt;1%) in 2019, increased to 34% in April 2020, and decreased to 9–12% in June–September 2020.</p></div><div><h3>Conclusions</h3><p><span>Substantial changes in commercial insurance claims for contraceptive services occurred during the beginning of the COVID-19 pandemic, including transient decreases in IUD and implant claims and increases in telehealth contraceptive counseling claims. Contraceptive claims data can be used by decision makers to identify service gaps and evaluate use of interventions like telehealth to improve contraceptive access, including during </span>public health emergencies.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"34 2","pages":"Pages 186-196"},"PeriodicalIF":2.8000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020\",\"authors\":\"Kathryn M. Curtis PhD,&nbsp;Aniket D. Kulkarni MBBS, MPH,&nbsp;Antoinette T. Nguyen MD, MPH,&nbsp;Lauren B. Zapata PhD,&nbsp;Katherine Kortsmit PhD, MPH,&nbsp;Ruben A. Smith PhD,&nbsp;Maura K. Whiteman PhD\",\"doi\":\"10.1016/j.whi.2023.10.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.</p></div><div><h3>Methods</h3><p><span><span><span>We analyzed commercial insurance claims using IQVIA PharMetrics Plus data from more than 9 million U.S. females aged 15–49 years, enrolled during any month, January 2019 through September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and </span>injectable contraception and monthly rates of pharmacy claims for </span>contraceptive pills, patches, and rings. We used Joinpoint </span>regression analysis<span> to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via telehealth.</span></p></div><div><h3>Results</h3><p>Monthly claims rates decreased for IUDs (−50%) and implants (−43%) comparing February 2020 with April 2020 but rebounded by June 2020. Monthly claims rates for injectables decreased (−19%) comparing January 2019 with September 2020, and monthly claims rates for pills, patches, and rings decreased (−22%) comparing July 2019 with September 2020. The percentage of claims for contraceptive counseling occurring via telehealth was low (&lt;1%) in 2019, increased to 34% in April 2020, and decreased to 9–12% in June–September 2020.</p></div><div><h3>Conclusions</h3><p><span>Substantial changes in commercial insurance claims for contraceptive services occurred during the beginning of the COVID-19 pandemic, including transient decreases in IUD and implant claims and increases in telehealth contraceptive counseling claims. Contraceptive claims data can be used by decision makers to identify service gaps and evaluate use of interventions like telehealth to improve contraceptive access, including during </span>public health emergencies.</p></div>\",\"PeriodicalId\":48039,\"journal\":{\"name\":\"Womens Health Issues\",\"volume\":\"34 2\",\"pages\":\"Pages 186-196\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Womens Health Issues\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1049386723001858\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Womens Health Issues","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1049386723001858","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

目的我们描述了 COVID-19 大流行初期避孕服务商业保险理赔的变化:我们使用 IQVIA PharMetrics Plus 数据对商业保险理赔进行了分析,这些数据来自 900 多万 15-49 岁的美国女性,她们在 2019 年 1 月至 2020 年 9 月期间的任何一个月都参加了保险。我们计算了宫内节育器 (IUD)、植入物和注射避孕药的月门诊报销率,以及避孕药、避孕贴和避孕环的月药房报销率。我们使用 Joinpoint 回归分析来确定每种避孕方法的月索赔率趋势何时发生统计学意义上的显著变化。我们计算了通过远程医疗提供避孕咨询的月报销比例:与 2020 年 2 月和 2020 年 4 月相比,宫内节育器(-50%)和皮下埋植剂(-43%)的月报销率有所下降,但到 2020 年 6 月又有所回升。与 2019 年 1 月和 2020 年 9 月相比,注射剂的月报销率下降了(-19%),与 2019 年 7 月和 2020 年 9 月相比,药片、避孕贴和避孕环的月报销率下降了(-22%)。通过远程医疗进行避孕咨询的理赔比例较低(结论:在 COVID-19 大流行初期,避孕服务的商业保险理赔发生了重大变化,包括宫内节育器和皮下埋植器理赔的短暂下降以及远程医疗避孕咨询理赔的增加。决策者可利用避孕药具理赔数据来确定服务缺口,并评估远程医疗等干预措施的使用情况,以改善避孕药具的获取,包括在公共卫生突发事件期间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020

Objective

We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.

Methods

We analyzed commercial insurance claims using IQVIA PharMetrics Plus data from more than 9 million U.S. females aged 15–49 years, enrolled during any month, January 2019 through September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and injectable contraception and monthly rates of pharmacy claims for contraceptive pills, patches, and rings. We used Joinpoint regression analysis to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via telehealth.

Results

Monthly claims rates decreased for IUDs (−50%) and implants (−43%) comparing February 2020 with April 2020 but rebounded by June 2020. Monthly claims rates for injectables decreased (−19%) comparing January 2019 with September 2020, and monthly claims rates for pills, patches, and rings decreased (−22%) comparing July 2019 with September 2020. The percentage of claims for contraceptive counseling occurring via telehealth was low (<1%) in 2019, increased to 34% in April 2020, and decreased to 9–12% in June–September 2020.

Conclusions

Substantial changes in commercial insurance claims for contraceptive services occurred during the beginning of the COVID-19 pandemic, including transient decreases in IUD and implant claims and increases in telehealth contraceptive counseling claims. Contraceptive claims data can be used by decision makers to identify service gaps and evaluate use of interventions like telehealth to improve contraceptive access, including during public health emergencies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.50
自引率
6.20%
发文量
97
审稿时长
32 days
期刊介绍: Women"s Health Issues (WHI) is a peer-reviewed, bimonthly, multidisciplinary journal that publishes research and review manuscripts related to women"s health care and policy. As the official journal of the Jacobs Institute of Women"s Health, it is dedicated to improving the health and health care of all women throughout the lifespan and in diverse communities. The journal seeks to inform health services researchers, health care and public health professionals, social scientists, policymakers, and others concerned with women"s health.
期刊最新文献
Community-dwelling Black Women's Experiences With Urinary Incontinence: A Qualitative Study. "Neither Side Really Knows… What an Abortion Is Like": A Qualitative Analysis of Medical Students' Experiences With Second-Trimester Procedural Abortions. A Mixed Methods Longitudinal Investigation of Maternal Depression Across the Perinatal Period Among Mothers Who Gave Birth During the COVID-19 Pandemic. Exploring Consumer Preferences for Pharmacy Provision of Mifepristone in the Human-centered Design Discovery Phase. "Women's Lives Are on the Line, and Our Hands Are Tied": How Television Is Reckoning With a Post-Dobbs America.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1